海尔生物涨2.01%，成交额3367.16万元，主力资金净流入254.31万元

Group 1 - The core viewpoint of the news is that Haier Biomedical has shown a positive stock performance with a 5.48% increase year-to-date and a market capitalization of 10.609 billion yuan as of January 12 [1] - As of December 31, the number of shareholders for Haier Biomedical is 13,100, a slight decrease of 0.10% from the previous period, while the average circulating shares per person increased by 0.10% to 24,261 shares [2] - The company reported a revenue of 1.761 billion yuan for the period from January to September 2025, reflecting a year-on-year decrease of 1.17%, and a net profit attributable to shareholders of 198 million yuan, down 35.83% year-on-year [2] Group 2 - Haier Biomedical has distributed a total of 788 million yuan in dividends since its A-share listing, with 452 million yuan distributed over the past three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 6.7302 million shares, an increase of 928,500 shares compared to the previous period, while Huabao Zhongzheng Medical ETF holds 5.4557 million shares, a decrease of 776,900 shares [3]